Literature DB >> 954661

Catecholamine involvement in episodic luteinizing hormone release in adult ovariectomized rats.

S V Drouva, R V Gallo.   

Abstract

This study was intended to examine the role of hypothalamic norepinephrine (HNE) and dopamine (HDA) in episodic luteinizing hormone (LH) release in adult ovariectomized rats. Unrestrained, unanesthetized rats with indwelling right atrial cannulae were bled continuously (30, 50, or 100 mul of whole blood/4-6 min for 3-4 hours), and the blood samples were analyzed for LH by radio-immunoassay. In other individual rats, changes in the hypothalamic levels of norepinephrine and dopamine after drug administration were determined by a radioisotopic-enzymatic catechol-O-methyl transferase assay. alpha-Methyl-p-tyrosine significantly decreased HNE and HDA concentrations but failed to alter episodic LH release. Two dopamine-beta-hydroxylase inhibitors (U-14,624 and FLA-63) caused marked reductions in HNE, small but not statistically significant increases in HDA, and an inhibition of episodic LH secretion. Apomorphine, a dopamine receptor stimulator, caused a transient (50-60 min) but marked inhibition of episodic LH release. Saline injection had no effect. Pimozide, a blocker of dopamine receptors, prevented the inhibitory effects seen following apomorphine. Although not studied in detail, pimozide alone did not appear to alter episodic LH secretion. These data suggest that in adult ovariectomized rats norepinephrine may be an excitatory neurotransmitter in the modulation of episodic LH release. The activation of dopamine receptors may be capable of inhibiting this release process. However, the apparent inability of pimozide alone to alter episodic LH discharge suggests that under physiological conditions dopamine may not play a role in the modulation of episodic LH secretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954661     DOI: 10.1210/endo-99-3-651

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Hypothalamic control of prolactin secretion.

Authors:  W Wuttke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977       Impact factor: 3.000

2.  Effect of cadmium on 24-h variations in hypothalamic dopamine and serotonin metabolism in adult male rats.

Authors:  A Lafuente; A González-Carracedo; A Romero; A I Esquifino
Journal:  Exp Brain Res       Date:  2003-01-22       Impact factor: 1.972

Review 3.  Amplitude and frequency modulation of pulsatile luteinizing hormone-releasing hormone release.

Authors:  J E Levine; P Chappell; L M Besecke; A C Bauer-Dantoin; A M Wolfe; T Porkka-Heiskanen; J H Urban
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

4.  Effects of 4 weeks treatment with chlorpromazine and/or trihexyphenidyl on the pituitary-gonadal axis in male paranoid schizophrenics.

Authors:  P Rinieris; J Hatzimanolis; M Markianos; C Stefanis
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

5.  Chronic estradiol-17β exposure suppresses hypothalamic norepinephrine release and the steroid-induced luteinizing hormone surge: role of nitration of tyrosine hydroxylase.

Authors:  Badrinarayanan S Kasturi; Sheba M J MohanKumar; Madhu P Sirivelu; Andrew C Shin; P S Mohankumar
Journal:  Brain Res       Date:  2012-11-26       Impact factor: 3.252

Review 6.  Afferent neuronal control of type-I gonadotropin releasing hormone neurons in the human.

Authors:  Erik Hrabovszky; Zsolt Liposits
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-20       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.